What we’re funding

$125 million over 9 years to establish a Targeted Translation Research Accelerator in chronic conditions, particularly diabetes and heart disease.

Desired outcomes

The purpose of this research funding is to:

  • improve the lives of patients living with chronic disease
  • create new jobs
  • lift Australia’s reputation as a health and medical research powerhouse.

Key elements

This program will:

  • support early stage health and medical research discoveries to reach proof-of-concept and progress to human clinical trials
  • establish philanthropic and business co-invest arrangements to support increased efforts.

Why it’s important

  • Chronic conditions impact millions of Australians.
  • The progress of early stage health and medical research often lacks investment.
  • It will help innovations progress to late stage research and commercial success with support from philanthropic and business co-funding.

An expert advisory committee will be established to identify areas of research priority, co-funding models with business and philanthropists, and mechanisms for support including grants. The Australian Medical Research Advisory Board will lead the committee.

Last updated: 
12 July 2018